Market Place
Sourcing Support
Government Enhances Oversight On Unauthorized GLP-1 Sales
24 Mar 2026 //
BUSINESS STD
Novo Nordisk receives FDA warning linked to US inspection in 2025
11 Mar 2026 //
REUTERS
Incyte Lung Cancer Expansion Hit by Issues at Novo Catalent Site
09 Mar 2026 //
BIOSPACE
FDA Cites Novo Nordisk Again For Misleading GLP-1 AD
05 Mar 2026 //
RAPS
Novo Earns FDA Untitled Letter For Apple-Inspired Ozempic Ad
04 Mar 2026 //
FIERCE PHARMA
FDA Cites Novo Nordisk For Airing Misleading Wegovy Ad
10 Feb 2026 //
RAPS
FDA Untitled Letters Target Drug Ads From Novo, Argenx, Sobi
10 Feb 2026 //
FIERCE PHARMA
Hims & Hers’ Woes Compound as FDA Hit Company With Warning Letter
10 Feb 2026 //
BIOSPACE
FDA Commissioner Pledges Crackdown On Compounding Practices
06 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Addresses Hims & Hers` Illegal Compounding
05 Feb 2026 //
GLOBENEWSWIRE
Compounder Sues Lilly, Novo, Claims Coordinated Crackdown
15 Jan 2026 //
BIOSPACE
US FDA Requests Removal of Suicide Warnings From Weight-loss Drug
13 Jan 2026 //
REUTERS
Novo Gets Warning Letter At Site Formerly Owned By Catalent
17 Dec 2025 //
FIERCE PHARMA
Novo Plant Issues May Mean Delays For Regeneron, Scholar Rock
13 Oct 2025 //
FIERCE PHARMA
Europe Warns of Surge in Illegal Obesity Drugs
05 Sep 2025 //
FIERCE PHARMA
Catalent`s Newly Acquired Novo Plant Under FDA Scrutiny
22 Aug 2025 //
FIERCE PHARMA
CDSCO issues Alert on Novo Drugs After Reported Theft
22 Aug 2025 //
ECONOMICTIMES
Novo Nordisk Broadens Legal Action to Safeguard Us Patients
06 Aug 2025 //
PR NEWSWIRE
Issues at Novo Nordisk`s Indiana site trip up Regeneron again
01 Aug 2025 //
FIERCE PHARMA
Novo Nordisk warns of counterfeit Ozempic in US
14 Apr 2025 //
REUTERS
Novo Nordisk calls out dangers of compounded GLP-1s in new ad
12 Feb 2025 //
FIERCE PHARMA
FDA warns online vendors selling unapproved weight-loss drugs
18 Dec 2024 //
REUTERS
Novo Nordisk Faces FDA Write-Up Over Semaglutide Plant Issues
31 Oct 2024 //
FIERCE PHARMA
Fake Ozempic: Batch Numbers Help Spread Dangerous Weight Loss Drugs
05 Sep 2024 //
REUTERS
Novo Nordisk`s Ozempic cuts dementia risk vs. Merck`s Januvia
12 Jul 2024 //
FIERCE PHARMA
Novo Nordisk Receives Complete Response Letter For Weekly Insulin Icodec
10 Jul 2024 //
GLOBENEWSWIRE
WHO issues warnings on fake copies of Novo Nordisk`s weight-loss drugs
21 Jun 2024 //
NCBNEWS
Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro
21 May 2024 //
REUTERS
Sanders issues dire warning about projected GLP-1 spending
16 May 2024 //
FIERCE PHARMA
US FDA finds control lapses at Catalent plant being sold to Novo
06 Feb 2024 //
REUTERS
Novo Nordisk shares fall after media report about quality lapses at U.S. plant
19 Sep 2023 //
REUTERS
FDA hits Novo Nordisk with CRL for its once-daily hemophilia drug concizumab
05 May 2023 //
ENDPTS
Novo Nordisk issues voluntary nationwide recall of Levemir®
07 May 2021 //
PRNEWSWIRE
Intercept slides on FDA safety flag for Ocaliva
22 Sep 2017 //
FIERCE PHARMA
Cipla’s Inhalable Insulin Fails to Get Approval for Trials on Indian Patients
06 Dec 2016 //
ECONOMIC TIMES
Novo Nordisk Inc. issues voluntary nationwide recall - GlucaGen HypoKit
08 Sep 2016 //
PR NEWSWIRE
Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
01 Apr 2015 //
PHARMALOT
